Sterile Filtration Market - Revenue Growth Expectations in the Near Future

 Overview:

The study involved four major activities in estimating the current size of the Sterile Filtration Market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sterile filtration  market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Major Revenue Gains:

The global sterile filtration market size is projected to reach USD 7.6 billion by 2025 from USD 5.1 billion in 2020, at a CAGR of 8.2%.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256410424

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the sterile filtration  industry.

The cartridge filters segment accounted for the largest share of the global sterile filtration market in 2019.

Based on product, the sterile filtration market is segmented into cartridge filters, capsule filters, membranes, syringe filters, bottle-top & table-top filtration systems, and accessories. In 2019, the cartridge filters segment accounted for the largest share of the sterile filtration market. The large share of this segment can primarily be attributed to the increasing use of different types of cartridge filters for larger processes requiring more filtration area and/or lower unit operating costs.

North America accounted for the largest share of the sterile filtration  market in 2019.

North America accounted for the largest share of the sterile filtration market in 2019. The large share of the North American region can be attributed to a large number of pharmaceutical and biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and stringent regulations for the pharmaceutical industry.

Global Leading Companies:

Some of the major players in the sterile filtration  market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), Parker Hannifin Corporation (US), Sterlitech Corporation (US), Alfa Laval AB (Sweden), and Thermo Fisher Scientific (US).

Recent Developments:

# In 2019, Merck (Germany) launched the Stericup Quick Release 500 ml Vacuum Filtration System

# In 2019, Merck (Germany)) expanded its distribution capacity in Gillingham, UK.

# In 2019, Sartorius (Germany) launched Sartolab MultiStation (filtration units).

# In 2018, Pall (US) established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China. This center is equipped with advanced bioprocessing equipment, including single-use cell culture solutions, cell clarification using acoustic wave technology, chromatography using automated packing techniques, viral clearance, and tangential flow filtration, to serve bioprocess engineering consultancies for China and broader Asia.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=256410424

European Hemostats & Sealants Market is Expecting a Major Revenue Surge in Near Future

 Overview of This Study:

The study involved four major activities to estimate the current size of the european hemostats and sealants market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Projected Revenue Surge:

The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%. The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the European hemostats and sealants (focused products) market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

Key Questions Addressed in the Report:

# What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?
# What are the key drivers and restraints in the hemostats and sealants market?
# What are the key brands in the hemostats and sealants market?
# Which are the key countries in the hemostats and sealants market?
# What are the most preferred brands amongst end users?

Data Triangulation:

To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the hemostats and sealants industry.

UK to grow at the highest rate during the forecast period (2019–2024)

The European hemostats and sealants market is geographically segmented into Germany, UK, France, Italy, and Spain. While Germany dominated the market in 2019, the UK is expected to register the highest CAGR in the market during the forecast period. Germany holds the largest share amongst all the European countries, owing to its larger patient population and comparatively higher number of surgeries, which will require the usage of hemostats and sealants.

Key Market Players:

Some of the prominent players in the European hemostats and sealants market are B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

Hospital Capacity Management Solutions Market - Major Monetary Gains are Expected by 2026

 Market Size Estimation Methodologies Followed:

The total size of the Hospital Capacity Management Solutions Market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach to calculate the revenue of different players in the hospital capacity management solutions market

The size of the global Hospital Capacity Management Solutions Market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global hospital capacity management solutions market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Projected Surge in Revenue Generation:

The global hospital capacity management solutions market is projected to reach USD 7.0 billion by 2026 from USD 3.2 billion in 2021, at a CAGR of 17.1% during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25396768

Global Growth Boosting Factors:

The growth in the market is mainly driven by factors such as the need for better capacity management in hospitals, need to curtail escalating healthcare costs, and the advantages of capacity management solutions in enhancing patient care and safety. Increasing patient volume due to the rising prevalence of chronic diseases and COVID-19 and the need to manage regulatory compliance through the effective utilization of capacity management solutions are further contributing to the growth of this market.

Data Triangulation:

After arriving at the overall market size-using the market size estimation processes explained above-the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Covid-19 Impact on the Hospital capacity management solutions Market

The current COVID-19 pandemic has resulted in a massive number of patients visiting healthcare facilities on a daily basis. As of May 2021, over 156 million cases of COVID-19 have been reported across Africa, Asia Pacific, the Americas, Europe, and Oceania. The virus has resulted in approximately 3.2 million deaths. With the COVID-19 pandemic, most countries, including the whole of Europe, the US, India, and Australia, among others, reported a surge in the number of patients being admitted in hospitals leading to a shortage of beds, equipment, and hospital staff. This had increased the demand of hospital capacity management solutions for better management of staff, bed, and devices.

Opportunity: IoT-based healthcare capacity management

Advancements in information technology have provided the industry with an ever-expanding array of options like Internet of Things (IoT), which has generated significant growth opportunities for healthcare capacity management vendors. The healthcare-based IoT platform is integrated with smart sensors over a cloud-based network, which allows hospitals and other healthcare organizations to monitor cold storage and other aspects of their operations that must be maintained at specific conditions to ensure quality patient care.

Through the implementation of IoT for asset monitoring and tracking of medical equipment, hospitals can access real-time data using smart sensors and devices and gain real-time visibility into the operational status. Also, IoT-based asset management aids in monitoring performance through a single dashboard, which tracks and analyzes various parameters for each asset. These advancements help in reducing healthcare costs and improving the overall quality of patient care.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=25396768

Asia-Pacific is the fastest-growing market for hospital capacity management solutions market during the forecast period.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high growth in this regional market can be attributed to the increasing government initiatives for eHealth, growing medical tourism, increasing need for management solutions due to the COVID-19 outbreak, and the increasing demand for quality healthcare

Key Market Players:

The major players in the global hospital capacity management solutions market are Cerner Corporation (US), McKesson Corporation (US), HealthStream (US), Stanley Healthcare (US), and Halma plc (US). Other prominent players in this market include Infosys (India), Teletracking Technologies, Inc. (US), NextGen Healthcare (US), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), Sonitor Technologies (US), Koninklijke Philips N.V. (Netherlands), Neusoft Corporation (China), Infinitt Healthcare Co., Ltd. (South Korea), JVS Group (India), Infor Systems (US), Care Logistics (US), WellSky (US), Simul8 Corporation (US), and Alcidion Corporation (Australia).

Active Pharmaceutical Ingredient Market is Expecting a Healthy Growth Rate in the Near Future

 Overview of This Study:

This study involved four major activities in estimating the current size of the Active Pharmaceutical Ingredient Market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Expected Growth in Revenue Generation:

The global active pharmaceutical ingredient market is projected to reach USD 248.3 billion by 2025 from USD 187.3 billion in 2020, at a CAGR of 5.8% during the forecast period.

Major Growth Boosting Factors:

The rising drug R&D, the increasing incidence of chronic diseases, the growing importance of generics, and the increasing uptake of biopharmaceuticals. On the other hand, unfavorable drug price control policies across various countries and high manufacturing costs are expected to restrain the growth of this market are the major factors driving the growth of this market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263

The oncology segment is expected to grow at the highest CAGR during the forecast period

The active pharmaceutical ingredient market, Based on application, is segmented into communicable diseases, oncology, cardiovascular diseases, diabetes, pain management, chronic respiratory diseases, and other therapeutic application. neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. In 2019, the oncology segment is expected to register the highest CAGR during the forecast period. Growth in this market segment is driven by the increasing demand for highly potent APIs (HPAPIs) for the treatment of cancer.

In 2019, the innovative APIs segment accounted for the largest share of the active pharmaceutical ingredients market

Based on type, the active pharmaceutical ingredients market is segmented into innovative and generic APIs. The innovative APIs segment accounted for the largest share of the global active pharmaceutical ingredients market in 2019. Increased FDA approvals for new molecular entities, high price of innovative APIs as compared to the generic drugs, increased focus on R&D by the innovator API companies are the factors contributing towards the growth of the innovative APIs segment.

Geographical Growth Dynamics:

North America was the largest regional market for active pharmaceutical ingredient market in 2019

The global active pharmaceutical ingredient market is segmented into North America, Europe, Asia, Latin America, and Rest of the World. In 2019, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia.

The large share of North America in the global market is attributed to the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. However, the market in the Asia is expected to grow at the highest CAGR during the forecast period. This can be attributed to the low manufacturing costs, growth in the increase in disposable income, the high prevalence of lifestyle- and age-related diseases, and government efforts to reform healthcare industry.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=263

Global Leading Players:

The global active pharmaceutical ingredient market is highly consolidated. Prominent players in the active pharmaceutical ingredients market include Pfizer Inc. (US), Novartis International AG (Switzerland), Merck & Co. (US), Teva Pharmaceutical Industries Ltd. (Israel), Mylan N.V. (US), Boehringer Ingelheim (Germany), F. Hoffmann-La Roche AG (Switzerland), Sanofi (France), AbbVie (US), Eli Lilly and Company (US), AstraZeneca (UK), Bristol-Myers Squibb (US), and GlaxoSmithKline plc (UK).

Healthcare Cloud Computing Market - Emerging Trends & Global Future Forecasts by 2027

 Major Growth Driving Factors:

The growth of the Healthcare Cloud Computing Market is mainly driven by factors such as the growing adoption of EHR, e-prescribing, telehealth, mHealth, and other healthcare IT solutions due to COVID-19; the increasing adoption of big data analytics, wearable devices, and IoT; increasing cloud deployment in the healthcare industry; better storage, flexibility, and scalability of data offered by cloud computing; the proliferation of new payment models and cost-efficiency of the cloud; and the dynamic nature of health benefit plan designs

On the other hand, data & security concerns and complex regulations governing cloud data centers are factors expected to restrain the market growth to a certain extent.

Projected Gain in Revenue Generation:

The global healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%.

Global Industry Segmentation:

In this report, the healthcare cloud computing market is classified into seven segments product, component, deployment model, service model, pricing model, end user, and region.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=347

Recent Developments:

# In February 2022, IBM (US) acquired Neudesic, LLC (US) which was aimed at expanding IBM's portfolio of hybrid multi-cloud services and further advance the company's hybrid cloud and AI strategy.

# In February 2022, Lyniate (US) acquired SAP SE (Germany) which was aimed at providing technology and consulting expertise to make it easier for clients to embrace a hybrid cloud approach and move mission-critical workloads from SAP solutions to the cloud for regulated and non-regulated industries.

# In January 2022 Francisco Partners (US) signed an agreement with IBM (US) to acquire healthcare data and analytics assets from IBM that are currently part of the Watson Health business, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings.

# In January 2022, IBM (US) acquired ENVIZI (Australia) which was aimed at building on IBM's growing investments in AI-powered software.

COVID-19 Impact on the Healthcare Cloud Computing Market

Over the past few months, the COVID-19 pandemic has upended many lives and businesses on an unprecedented scale. However, if there is one sector that has emerged stronger from this event, it would be the cloud computing industry. While many organizations are finding it difficult to run smoothly, the companies that opted for cloud computing infrastructure are functioning well. Going for cloud services eliminates the inconvenience of remote working as one can communicate, collaborate, and monitor all the work while helping the employees stay safe in the confinement of their homes.

Especially in the healthcare industry, where data serves as the primary asset today, storage and management of data is cost-prohibitive, thereby increasing the additional expenditures related to the requirement of expensive servers. In such cases, cloud computing assists in hassle-free data storage and backup because of its scalability. Cloud also enables one to scale back during hectic days.

“North America was the largest regional market for healthcare cloud computing market in 2021“

In 2021, North America accounted for the largest share of the healthcare cloud computing market. Factors like technological advancements, EHR incentive programs by Medicaid & Medicare, and high healthcare expenditure contribute to the growth of this region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=347

Opportunities: Emergence of telecloud and telehealth consultations

The convergence of wireless technology and the cloud is proving to be a very strong mechanism for patient care delivery to remote locations. In several countries, most physicians and specialists work in metros and cities. Hence, advanced care facilities are only available in such places, leaving patients in rural areas unattended. This problem can be addressed through the use of a telecloud, as it enables physicians and healthcare specialists to diagnose and treat patients over large distances in real-time and at affordable costs.

Clinicians have been focusing on remote monitoring of affected patients due to the COVID-19 pandemic and the contagiousness of the disease. Physical assistance is taking a toll as there are increasing cases of doctors getting infected with the pandemic despite proper protection and care. The Italian Doctors Association stated that in March 2020, at least 50 doctors lost their lives treating COVID-19. It is, therefore, essential to minimize physical assistance and encourage telehealth. Thus, telehealth that includes remote monitoring of patients and the use of interactive medicines is expected to gain traction in the coming years.

Environmental Testing Equipment Market - Emerging Tech Innovations Majorly Boosts the Global Revenue Growth

 Major Objectives Behind This Study:

# To define, describe, and measure the global Environmental Testing Equipment Market by product, platform, application, end user, and region.

# To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global environmental testing equipment market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To estimate the market size and growth potential of the market segments and subsegments with respect to five key regions—North America (includes the US & Canada), Europe (includes Germany, France, UK, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.

# To strategically analyze the market structure with key players and their core competencies in the global environmental testing equipment market.

# To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy excellence and strength of product portfolio.

# To track and analyze competitive developments such as product launches & approvals; acquisitions; expansions; and partnerships, agreements, & collaborations in the environmental testing equipment market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149706080

Research Methodologies Opted:

Primary Research:

Extensive primary research was conducted after acquiring knowledge about the environmental testing equipment market scenario through secondary research. A significant number of primary interviews were conducted from both the demand (Government agencies and municipal authorities, environmental testing laboratories, industrial product manufacturers, agriculture, forestry, and geology departments, commercial end users) and the supply sides (developers, manufacturers, and distributors of environmental testing equipment). The primaries interviewed for this study include experts from the environmental testing equipment industry, such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering environmental testing equipment and consumables across the globe as well as administrators and purchase managers of demand-side end users.

Secondary Research:

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the environmental testing equipment market. A database of the key industry leaders was also prepared using secondary research.

Projected Growth in Revenue Generation:

The global environmental testing equipment market is estimated to reach USD 1.6 billion by 2027 from USD 1.1 billion in 2022, at a CAGR of 7.6% during the forecast period (2022-2027).

Major Growth Influencing Factors:

Growth in the environmental testing equipment market is mainly driven by the rising levels of environmental pollution worldwide, increasing efforts from public/private organizations to raise awareness about environment protection, privatization of environmental testing and treatment services, and increasing funding on wastewater treatment projects/programs. Increasing industrial activities post COVID-19, and the growing utilization of mobile & portable systems are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, high capital investments for accurate and sensitive analytical testing and inadequate supporting infrastructure coupled with the shortage of skilled professionals are factors expected to limit market growth to a certain extent in the coming years.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=149706080

Opportunity: Increasing industrial activities post COVID-19

The COVID-19 pandemic has triggered the sharpest downturn in the world economy since the Great Depression. In 2020, the global average daily consumption of petroleum and other liquid fuels saw a major decline from the previous year's average consumption. However, this fall in global petrochemical production is expected to reverse in post covid years. The Energy Information Agency (EIA) estimated that fall in production would reverse in 2022. Given their high pollutant emissions, the growth of these industries in the coming years can be expected to provide strong growth opportunities for environmental testing equipment manufacturers.

Drug Discovery Services Market - Major Growth Opportunities for Leading Players Across Geographies

 Overview of This Study:

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global Drug Discovery Services Market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Revenue Growth Dynamics:

The global Drug discovery services market is projected to reach USD 31.4 billion by 2026 from USD 16.1 billion in 2021, at a CAGR of 14.3% during the forecast period of 2021 to 2026.

Major Growth Driving Factors:

Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing services, initiatives for research on rare diseases and orphan drugs, and the high cost of in-house drug development are creating new revenue pockets in the drug discovery services market. On the other hand, stringent regulations governing drug discovery and animal usage are expected to restrain market growth to a certain extent. The shortage of skilled professionals poses a challenge for drug discovery service providers.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129

North America was the largest regional market for Drug discovery services Market in 2020.

The global drug discovery services market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for drug discovery services with an estimated share of in 2020. This can be attributed to the presence of well-established CROs, rising R&D expenditure by pharmaceutical & biopharmaceutical companies, rapid growth in the biosimilar and biologics markets, and the availability of the latest techniques, instruments, and facilities for drug discovery research in the region.

Leading Companies:

The global drug discovery services market is competitive, with Laboratory Corporation of America Holdings (US), Charles River Laboratories International Inc. (US), WuXi AppTec (China), and Thermo Fisher Scientific Inc. (US) together major share of the global market.

WuXi AppTec (China) has a comprehensive discovery and development services portfolio. It has a strong customer base, mainly in China, the US, Germany, Iceland, Israel, and Korea. To maintain its leading position in the market, the company mainly focuses on maintaining the quality of services delivered and adapting quickly to transformational and innovative conditions. The company is actively focusing on expansions and service launches to improve its capability and capacity in the global market. The company has conducted two expansions and two service launches in the last four years. For example, its subsidiary WuXi Advanced Therapies Inc. (WuXi ATU) opened a new process development and commercial manufacturing facility in Lin-gang, Shanghai.

Laboratory Corporation of America Holdings (US) is one of the leading players in the global drug discovery services market. The company’s strong focus on a broad range of customers, technology-enabled solutions, investments in joint ventures & partnerships, and comprehensive quality systems and processes contribute to the growth of the company’s market share. The company focuses on organic and inorganic growth strategies such as acquisitions and expansions to enhance its share in the global drug discovery services market. The company acquired Toxicon to expand its footprint in the bioanalytical testing and drug discovery services markets. Additionally, in September 2019, LabCorp established a new R&D center in Shanghai.

Thermo Fisher Scientific (US) offers a complete and integrated portfolio of discovery services. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. The company gained more than USD 12 billion in revenue in 2020 from its Life Sciences Solutions segment, which provides drug discovery services. In 2021, Thermo Fisher Scientific acquired PPD to strengthen its drug discovery service portfolio.

Charles River Laboratories (US) is a global drug discovery service CRO with a comprehensive portfolio of drug discovery and early-stage development products and services. The company has made multiple acquisitions, partnerships, and collaborations. An integrated early-stage service portfolio, pharmaceutical manufacturing support portfolio, deep scientific expertise, a diversified global presence, and a flexible & customized environment to provide solutions have ensured strong revenue and expanded its market position.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=138732129

Recent Developments in thr Global Industry:

# In December 2021, Curia (US) launched messenger RNA (mRNA) solution, which includes discovery, process development, and mRNA drug substance production, through large-scale lipid manufacturing, lipid nanoparticle (LNP) formulation, and development for full-scale sterile fill-finish services.

# In September 2021, Eurofins collaborated with Liverpool ChiroChem Ltd to provide enhanced chemical expertise by accessing LCC’s fragment library and PROTAC linker molecules to augment their integrated drug discovery platform, DiscoveryOne.